Aller au contenu principal

Psychiatrie-Comorbidités-Addictions (PSYCOMadd)

The 20 latest publications

Title Authors Publication date Source
Reduction of alcohol use and increase in psychological flexibility after a naturalistic psychedelic experience: a retrospective survey Lana Strika-Bruneau, Ammar Amirouche, Vincent Verroust, Bruno Roméo, Amine Benyamina 03/01/24 Alcohol and Alcoholism
Opinions of French psychiatrists on the regulatory status of cannabis: Results from the “PsyCan – Encéphale” national online survey Amine Benyamina 01/01/24 L'Encephale
Women and alcohol: From risky use to addiction, the issues at stake L. Karila 12/01/23 Revue de l'Infirmiere
Women and alcohol, the addictologist's point of view and treatment Amine Benyamina 12/01/23 Revue de l'Infirmiere
Improvement in OCD symptoms associated with serotoninergic psychedelics: a retrospective online survey Vincent Verroust 12/01/23 Scientific Reports
Antioxidant Effects of Catechins (EGCG), Andrographolide, and Curcuminoids Compounds for Skin Protection, Cosmetics, and Dermatological Uses: An Update Raphaël Serreau 07/01/23 Antioxidants
Articulating acceptance and commitment therapy to psychedelic-assisted psychotherapy in addictology Lana Strika-Bruneau, Amine Benyamina 06/01/23 Evolution Psychiatrique
Validation of a data collection set for the psychiatric, addiction, sleep and chronobiological assessments of patients with depression: A Delphi study for the SoPsy-depression French national cohort Amine Benyamina 04/01/23 L'Encephale
Impact of a Naturalistic Psychedelic Experience on Smoking: A Retrospective Survey Bruno Roméo, L. Strika, Ammar Amirouche, Vincent Verroust, Amine Benyamina 01/01/23 Journal of Psychoactive Drugs
Development, psychometric validation, and cross-cultural comparison of the "Instagram Motives Questionnaire" (IMQ) and the "Instagram Uses and Patterns Questionnaire" (IUPQ) L. Karila 01/01/23 Journal of Behavioral Addictions
A Review of Synthetic Access to Therapeutic Compounds Extracted from Psilocybe Raphaël Serreau, Ammar Amirouche, Amine Benyamina 01/01/23 Pharmaceuticals
Impact of cannabis use and its cessation on the dosage and the efficacy of antipsychotic drugs in in- and outpatients with schizophrenia taking medication: A systematic review and meta-analysis Ophélie Rault, Bruno Roméo, Eirini Rari, Amine Benyamina, Catherine Martelli 12/01/22 Journal of Psychiatric Research
A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs Vincent Verroust 11/01/22 European Neuropsychopharmacology
Changes in Alcohol Consumption among Users of an Internet Drug Forum during a COVID-19 Lockdown Alain Dervaux 11/01/22 International Journal of Environmental Research and Public Health
Cannabidiol in the context of substance use disorder treatment: A systematic review Victoria Paulus, Amine Benyamina, L. Karila 09/01/22 Addictive Behaviors
Women who use illicit substances Sarah Coscas, L. Karila, Amine Benyamina 01/01/22 Revue Sage - Femme
Cannabis Cessation, Inflammatory Markers and Schizophrenia Bruno Roméo, Catherine Martelli, Amine Benyamina, Nora Hamdani 01/01/22 Journal of Dual Diagnosis
Prolonged Agranulocytosis Despite a Granulocyte Colony-Stimulating Factor Treatment during Clozapine Treatment: A Case Report Bruno Roméo, Eirini Rari 01/01/22 Journal of Clinical Psychopharmacology
First-episode psychosis following vaccination against yellow fever: A case report Bruno Roméo, Eirini Rari, A. Mazari, A. Toullec, Catherine Martelli, Amine Benyamina 12/01/21 L'Encephale
Editorial: Purple Haze: Issues on Cannabis Legalization Amine Benyamina 11/10/21 Frontiers in Psychiatry

Number of publications of the laboratory by scientific field (2016-2021)

Every paper can be classified in one or more scientific fields. The figure below shows the lab's number of publications in each scientific field, according to the ASJC classification (Elsevier)